Additional file 4 of Cost-effectiveness of respiratory syncytial virus vaccines in post-marketing settings: a systematic review and meta-analysis
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Material 4. Scenario for data preparation. Equations and assumptions for calculating incremental net benefit and its variance, estimating missing dispersion measures, and converting monetary values to 2023 US dollars
Source: Figshare
Authors: Mengyao Mu, Yang Deng, Zhanwei Du, Yi Zhao
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W7233569394
